Inqovi

Generic name:cedazuridine and decitabine [ SED-az-URE-i-deen-and-de-SIT-a-been ]
Drug class:Antineoplastic combinations

Medically reviewed by Judith Stewart, BPharm. Last updated on Nov 17, 2020.

What is Inqovi?

Inqovi contains a combination of cedazuridine and decitabine.

Inqovi is a prescription medicine that is used to treat treat adults with myelodysplastic syndromes (MDS, including chronic myelomonocytic leukemia (CMML). Myelodysplastic syndromes are types of blood or bone marrow disorders.

It is not known if Inqovi is safe or effective in children..

Warnings

Inqovi affects your immune system. You may get infections more easily, even serious or fatal infections. Call your doctor if you have a fever, chills, cough, mouth sores, or unusual bleeding or bruising.

Do not give Inqovi to other people, even if they have the same symptoms that you have. It may harm them.

Before taking this medicine

To make sure Inqovi is safe for you, tell your doctor if you have ever had::

• kidney disease; or

• liver disease.

You may need to have a negative pregnancy test before starting this treatment.

Cedazuridine and decitabine can harm an unborn baby or cause birth defects if the mother or the father is using this medicine.

• If you are a woman, do not use Inqovi if you are pregnant. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 6 months after your last dose.

• If you are a man, use effective birth control if your sex partner is able to get pregnant. Keep using birth control for at least 3 months after your last dose.

• Tell your doctor right away if a pregnancy occurs while eith...